Friday, November 6, 2026||
MultiKhabarMultiKhabar

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

Share:WhatsAppFacebookX (Twitter)Telegram
EXECUTIVE SUMMARY

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

Key Takeaways

  • Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction.
  • The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
  • The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on CNBC Business

Visit Publisher Site →

Related News

🇺🇸 United States
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play